| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $145.9M | — |
| Cost of Revenue | $86.6M | — |
| R&D Expense | $50.1M | +532.7% |
| SG&A Expense | $56.9M | +215.2% |
| Operating Income | -$63.1M | -4957.9% |
| Interest Expense | $2K | -72.9% |
| Pre-tax Income | -$77.9M | -148.5% |
| Income Tax | $427K | — |
| Net Income | -$78.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $203.0M | — |
| Accounts Receivable | $37.5M | — |
| Inventory | $4.4M | — |
| Current Assets | $390.1M | — |
| Total Assets | $416.7M | +44.7% |
| Current Liabilities | $125.3M | — |
| Total Liabilities | $129.0M | +591.8% |
| Stockholders' Equity |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.3M | -1923.2% |
| Capital Expenditures | $2.3M | +1264.1% |
| Investing Cash Flow | -$13.3M | +95.4% |
| Financing Cash Flow | $217.8M | -24.6% |
| Free Cash Flow | -$25.7M | -1838.6% |
| -2245.3% |
| EPS (Basic) | -$0.64 | +96.1% |
| EPS (Diluted) | -$0.64 | +96.1% |
| $287.7M |
| +1687.8% |